Respiri Limited (AU:RSH) has released an update.
Respiri Limited is making strides in the healthcare sector with a 56% reduction in patient rehospitalizations and favorable regulatory conditions, including anticipated changes that could enhance revenue. The company is actively assessing significant acquisitions, with a strong pipeline of 250,000 patients and 29 clients contracted, contributing to an annual recurring revenue of $3.8 million.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
